Cargando…
Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic Review
Introduction: Biological disease-modifying anti-rheumatic drugs (bDMARDs) targeting interleukin (IL)-6 and IL-1β represent a steroid-sparing first-line therapy used in systemic-onset juvenile idiopathic arthritis (sJIA). Recently, the occurrence of pulmonary alveolar proteinosis (PAP) in sJIA patien...
Autores principales: | Zekre, Franck, Duncan, Anita, Laurent, Audrey, Tusseau, Maud, Pescarmona, Rémi, Collardeau-Frachon, Sophie, Ohlmann, Camille, Viel, Sébastien, Reix, Philippe, Benezech, Sarah, Belot, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095381/ https://www.ncbi.nlm.nih.gov/pubmed/37048785 http://dx.doi.org/10.3390/jcm12072702 |
Ejemplares similares
-
“P(2)RY(8)-son” break of tolerance promotes SLE
por: Tusseau, Maud, et al.
Publicado: (2021) -
A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
por: Viel, Sébastien, et al.
Publicado: (2018) -
NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to Adulthood
por: Bardet, Juliette, et al.
Publicado: (2021) -
Treatment of MAS and HLH
por: Belot, Alexandre
Publicado: (2014) -
Therapeutic Approach of Very Early-Onset Inflammatory Bowel Disease in a Loeys–Dietz Syndrome Child
por: Opréa, Alina, et al.
Publicado: (2021)